The inflammatory chemokine CCL5 and cancer progression.
Aldinucci D, Colombatti A. · 2014
Read The inflammatory chemokine CCL5 and cancer progression. by Aldinucci D, Colombatti A. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3910068.txt.
Description
Donatella Aldinucci and Alfonso Colombatti review, in Mediators of Inflammation in 2014, how a small immune signal protein called CCL5 helps cancers grow and spread. CCL5 and its receptor CCR5 were once seen mainly as guards of immunity and inflammation. Cancer cells, the review shows, hijack that system for their own ends.
The pair gather evidence from blood cancers, lymphomas, and many solid tumors. CCL5 can drive tumor cell growth, help cancer spread to new sites, and build a shield of immune suppression around the tumor. They close by surveying drug ideas that block CCL5 from binding CCR5, cut its release, or break the tumor-cell signals that trigger it, pointing to a possible new line of cancer treatment.
Catalog record
| CREATOR | Aldinucci D, Colombatti A. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |